Evidence map›Paper›PMID 41348251›Full record

ReviewMolecular genetics and genomics : MGG2025

Bioinformatics and artificial intelligence in genomic data analysis: current advances and future directions.

David B Olawade, Ayomikun Kade, Eghosasere Egbon, Sunday Oluwadamilola Usman, Oluwaseun Fapohunda, James Ijiwade, Covenant Ebubechi Ogbonna

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular genetics and genomics : MGG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Evolutionary Bioinformatics Expands its Breadth.Evolutionary bioinformatics online · 2026
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David B OlawadeDepartment of Allied and Public Health, School of Health, Sport and Bioscience, University of East London, London, UK. d.olawade@yorksj.ac.uk.ORCID http://orcid.org/0000-0003-0188-9836
Ayomikun KadeSchool of Life Sciences, Gibbet Hill, University of Warwick, Warwick, UK.
Eghosasere EgbonDepartment of Tissue Engineering and Regenerative Medicine, Faculty of Life Science Engineering, FH Technikum, Vienna, Austria.
Sunday Oluwadamilola UsmanDepartment of Systems and Industrial Engineering, University of Arizona, Tucson, USA.
Oluwaseun FapohundaDepartment of Chemistry and Biochemistry, University of Arizona, Tucson, USA.
James IjiwadeDepartment of Chemistry, Faculty of Science, University of Ibadan, Ibadan, Nigeria.
Covenant Ebubechi OgbonnaDepartment of Civil/Industrial Engineering, Bahçeşehir Cyprus University, Lefkosa-Guzelyurt, Alaykoy, Mersin-10, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exponential growth of genomic data from next-generation sequencing technologies has created an urgent need for advanced computational approaches that can efficiently process, integrate, and interpret complex multi-dimensional biological information. This comprehensive review examines how artificial intelligence (AI), particularly machine learning and deep learning, is transforming genomic data analysis and addressing critical limitations of traditional bioinformatics methods. A thorough literature search was conducted across PubMed, Scopus, and Google Scholar databases, targeting peer-reviewed studies published between 2010 and 2024. This review addresses a critical knowledge gap by synthesizing current AI applications across the genomic analysis pipeline, from variant calling to multi-omics integration and personalized medicine, whilst critically evaluating emerging technologies including explainable AI and federated learning. AI methods have significantly improved accuracy in variant calling, gene expression profiling, and disease risk prediction. Key findings demonstrate that deep learning models achieve superior performance in complex pattern recognition, whilst explainable AI addresses the "black box" problem essential for clinical adoption. Federated learning enables privacy-preserving collaborative research across institutions. However, significant challenges remain, including data standardization, computational costs, algorithm interpretability, and ethical considerations surrounding privacy and algorithmic bias. Future directions include quantum computing integration and AI-enhanced CRISPR technologies. This review concludes that whilst AI represents a transformative force in genomic research, successful clinical translation requires addressing current technical and ethical challenges through interdisciplinary collaboration, robust validation frameworks, and responsible implementation strategies prioritizing patient safety and data security.

Indexed as

Artificial IntelligenceComputational BiologyGenomicsData AnalysisDeep LearningHigh-Throughput Nucleotide SequencingHumansMachine LearningArtificial intelligenceDeep learningGenomic data analysisMachine learningMulti-omics integrationPersonalized medicine

Identifiers

PMID41348251

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.